Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1
暂无分享,去创建一个
[1] Martina,et al. Co-Localization of Transforming Growth Factor ,2 with c1 (I) Procollagen mRNA in Tissue Sections of Patients with Systemic Sclerosis , 2003 .
[2] M. Landthaler,et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. , 2001, Arthritis and rheumatism.
[3] W. Strauss. Preparation of Genomic DNA from Mammalian Tissue , 1993, Current protocols in immunology.
[4] Toshiyuki Yamamoto,et al. Monocyte Chemoattractant Protein-1 Enhances Gene Expression and Synthesis of Matrix Metalloproteinase-1 in Human Fibroblasts by an Autocrine IL-1α Loop1 , 2000, The Journal of Immunology.
[5] J. Lapage,et al. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. , 2000, Kidney international.
[6] Yan Zhang,et al. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. , 1999, Journal of immunology.
[7] F. Maxfield,et al. Unique Cellular Events Occurring during the Initial Interaction of Macrophages with Matrix-retained or Methylated Aggregated Low Density Lipoprotein (LDL) , 1999, The Journal of Biological Chemistry.
[8] S. Sato. Abnormalities of adhesion molecules and chemokines in scleroderma. , 1999, Current opinion in rheumatology.
[9] R. Silver,et al. Assessment and management of scleroderma lung disease. , 1999, Current opinion in rheumatology.
[10] R. Strieter,et al. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. , 1999, Journal of immunology.
[11] F. Thaiss,et al. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β , 1999 .
[12] N. Elshourbagy,et al. Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist. , 1999, The Journal of pharmacology and experimental therapeutics.
[13] P. Erne,et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[14] 直子 加藤,et al. Graft-Versus-host Disease , 1999 .
[15] D. Furst,et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. , 1999, Blood.
[16] L. Carrel,et al. Germ cell development in the XXY mouse: evidence that X chromosome reactivation is independent of sexual differentiation. , 1999, Developmental biology.
[17] S Gordon,et al. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[18] T. Kodama,et al. The macrophage scavenger receptor type A directs modified proteins to antigen presentation , 1999, European journal of immunology.
[19] S. Gordon,et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. , 1999, Journal of immunology.
[20] S. Gordon,et al. Class A scavenger receptors and the phagocytosis of apoptotic cells. , 1999, Immunology letters.
[21] M. Landthaler,et al. Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis , 1999, Rheumatology International.
[22] A. Panduro,et al. Treatment with anti-tumor growth factor β antibodies influences an altered pattern of cytokines gene expression in injured rat liver , 1998 .
[23] T. Moody,et al. Transforming growth factor-beta expression in mouse lung carcinogenesis. , 1998, Experimental lung research.
[24] R. Abraham,et al. Modulation of T cell cytokine profiles and peptide-MHC complex availability in vivo by delivery to scavenger receptors via antigen maleylation. , 1998, Journal of immunology.
[25] S. Jimenez,et al. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. , 1998, The New England journal of medicine.
[26] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[27] Anita B. Roberts,et al. REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .
[28] Y. Yoshida,et al. The human hair follicle: a reservoir of CD40+ B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. , 1998, The Journal of investigative dermatology.
[29] A. Panduro,et al. Treatment with anti-transforming growth factor beta antibodies influences an altered pattern of cytokines gene expression in injured rat liver. , 1998, Biochimica et biophysica acta.
[30] D. Salant,et al. Role of MCP‐1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis , 1997, Journal of leukocyte biology.
[31] C. Esser,et al. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1997, Molecular pharmacology.
[32] K. Tryggvason,et al. Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. , 1997, Immunology letters.
[33] T. Mak,et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. , 1997, Immunity.
[34] C. Mackay,et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. , 1997, Circulation.
[35] N. Duraiswamy,et al. Reversal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment. , 1996, Journal of immunology.
[36] M. Okamura,et al. Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages. , 1996, Biochimica et biophysica acta.
[37] G. Opdenakker,et al. Leukocyte migration and activation by murine chemokines. , 1996, Immunobiology.
[38] Lawrence Da. Transforming growth factor-beta: a general review. , 1996, European cytokine network.
[39] S. Phan,et al. Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors* , 1996, The Journal of Biological Chemistry.
[40] L. Picker,et al. Lymphocyte Homing and Homeostasis , 1996, Science.
[41] G. Graham,et al. Specificity and reciprocity in the interactions between TGF-beta and macrophage inflammatory protein-1 alpha. , 1996, Journal of immunology.
[42] A. Takeshita,et al. TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells. , 1995, Journal of immunology.
[43] P. Gray,et al. Chemokine expression in murine experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.
[44] S. Jimenez,et al. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. , 1995, Pathobiology : journal of immunopathology, molecular and cellular biology.
[45] S. Gordon,et al. Murine Mφ scavenger receptor: Adhesion function and expression , 1994 .
[46] K. Cooper,et al. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. , 1994, Journal of immunology.
[47] R. Strieter,et al. Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts. , 1994, The American journal of pathology.
[48] S. Wahl,et al. Reversal of acute and chronic synovial inflammation by anti- transforming growth factor beta , 1993, The Journal of experimental medicine.
[49] A. Cerami,et al. Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78. , 1991, Journal of immunology.
[50] E. Leroy,et al. A Possible Role for Transforming Growth Factor-β in Systemic Sclerosis , 1990 .
[51] T. Krieg,et al. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. , 1990, The Journal of clinical investigation.
[52] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[53] B. Jaffee,et al. Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. , 1983, Cellular immunology.
[54] J. Sprent,et al. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.